Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant genetic disease manifested by formation of telangiectasias and visceral vascular malformations of organ systems, including the skin, lungs, gastrointestinal tract, brain, and liver. Hepatic involvement may lead to portal hypertension, high-output cardiac failure, and biliary strictures.
. Abdominal CT showing markedly dilated portal vein, hepatic vein, and inferior vena cava with heterogeneous enlarged liver and innumerable hyperdense nodules.
Liver angioectasias in HHT can cause increased preload leading to high-output heart failure. Recognition of imaging findings is important for determining diagnosis and severity of disease in patients with suspected HHT. Per AASLD guidelines, hepatic artery embolization should be avoided, and the only definitive treatment in symptomatic patients with HHT is liver transplantation.
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